|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6776792B1
(en)
|
1997-04-24 |
2004-08-17 |
Advanced Cardiovascular Systems Inc. |
Coated endovascular stent
|
|
DK1019111T3
(da)
|
1998-04-27 |
2002-10-14 |
Surmodics Inc |
Overtræk der frigiver bioaktivt stof
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
HUP0200860A2
(en)
|
1999-04-26 |
2002-07-29 |
Gmp Vision Solutions Inc |
Stent device and method for treating glaucoma
|
|
US6790228B2
(en)
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
US7807211B2
(en)
|
1999-09-03 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of an implantable medical device
|
|
US7682647B2
(en)
|
1999-09-03 |
2010-03-23 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of a drug eluting implantable medical device
|
|
US20070032853A1
(en)
|
2002-03-27 |
2007-02-08 |
Hossainy Syed F |
40-O-(2-hydroxy)ethyl-rapamycin coated stent
|
|
US6908624B2
(en)
*
|
1999-12-23 |
2005-06-21 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US7682648B1
(en)
|
2000-05-31 |
2010-03-23 |
Advanced Cardiovascular Systems, Inc. |
Methods for forming polymeric coatings on stents
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
US6451373B1
(en)
|
2000-08-04 |
2002-09-17 |
Advanced Cardiovascular Systems, Inc. |
Method of forming a therapeutic coating onto a surface of an implantable prosthesis
|
|
WO2002017831A2
(en)
*
|
2000-08-30 |
2002-03-07 |
John Hopkins University |
Devices for intraocular drug delivery
|
|
US6953560B1
(en)
|
2000-09-28 |
2005-10-11 |
Advanced Cardiovascular Systems, Inc. |
Barriers for polymer-coated implantable medical devices and methods for making the same
|
|
US6783793B1
(en)
|
2000-10-26 |
2004-08-31 |
Advanced Cardiovascular Systems, Inc. |
Selective coating of medical devices
|
|
US7807210B1
(en)
|
2000-10-31 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Hemocompatible polymers on hydrophobic porous polymers
|
|
EP1339438B1
(en)
|
2000-11-29 |
2005-10-19 |
Allergan Inc. |
Preventing transplant rejection in the eye
|
|
US6824559B2
(en)
|
2000-12-22 |
2004-11-30 |
Advanced Cardiovascular Systems, Inc. |
Ethylene-carboxyl copolymers as drug delivery matrices
|
|
US6663662B2
(en)
|
2000-12-28 |
2003-12-16 |
Advanced Cardiovascular Systems, Inc. |
Diffusion barrier layer for implantable devices
|
|
EP1365738A2
(en)
*
|
2001-01-26 |
2003-12-03 |
Bausch & Lomb Incorporated |
Improved process for the production of sustained release drug delivery devices
|
|
US6780424B2
(en)
|
2001-03-30 |
2004-08-24 |
Charles David Claude |
Controlled morphologies in polymer drug for release of drugs from polymer films
|
|
US20020148138A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Egan Brian A. |
Smart tread boot covers
|
|
US7488303B1
(en)
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
DE60225815T2
(de)
|
2001-04-07 |
2009-02-05 |
Glaukos Corp., Laguna Hills |
Glaukom-stent für die glaukom-behandlung
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US6712845B2
(en)
|
2001-04-24 |
2004-03-30 |
Advanced Cardiovascular Systems, Inc. |
Coating for a stent and a method of forming the same
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
EP1387671A1
(en)
|
2001-05-03 |
2004-02-11 |
MASSACHUSETTS EYE & EAR INFIRMARY |
Implantable drug delivery device and use thereof
|
|
WO2002089699A2
(en)
|
2001-05-03 |
2002-11-14 |
Glaukos Corporation |
Medical device and methods of use for glaucoma treatment
|
|
US6656506B1
(en)
|
2001-05-09 |
2003-12-02 |
Advanced Cardiovascular Systems, Inc. |
Microparticle coated medical device
|
|
US6743462B1
(en)
|
2001-05-31 |
2004-06-01 |
Advanced Cardiovascular Systems, Inc. |
Apparatus and method for coating implantable devices
|
|
EP2316394B1
(en)
|
2001-06-12 |
2016-11-23 |
The Johns Hopkins University |
Reservoir device for intraocular drug delivery
|
|
US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
|
US6695920B1
(en)
|
2001-06-27 |
2004-02-24 |
Advanced Cardiovascular Systems, Inc. |
Mandrel for supporting a stent and a method of using the mandrel to coat a stent
|
|
US6565659B1
(en)
|
2001-06-28 |
2003-05-20 |
Advanced Cardiovascular Systems, Inc. |
Stent mounting assembly and a method of using the same to coat a stent
|
|
US7682669B1
(en)
|
2001-07-30 |
2010-03-23 |
Advanced Cardiovascular Systems, Inc. |
Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
US8303651B1
(en)
|
2001-09-07 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
|
|
CN1585627A
(zh)
|
2001-09-14 |
2005-02-23 |
弗朗西斯J·马丁 |
用于持续释放治疗剂的显微制作的纳米微孔装置
|
|
US7285304B1
(en)
|
2003-06-25 |
2007-10-23 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
|
US7989018B2
(en)
|
2001-09-17 |
2011-08-02 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
|
US7223282B1
(en)
|
2001-09-27 |
2007-05-29 |
Advanced Cardiovascular Systems, Inc. |
Remote activation of an implantable device
|
|
US6753071B1
(en)
|
2001-09-27 |
2004-06-22 |
Advanced Cardiovascular Systems, Inc. |
Rate-reducing membrane for release of an agent
|
|
US6709514B1
(en)
|
2001-12-28 |
2004-03-23 |
Advanced Cardiovascular Systems, Inc. |
Rotary coating apparatus for coating implantable medical devices
|
|
US20030180294A1
(en)
*
|
2002-02-22 |
2003-09-25 |
Devries Gerald W. |
Methods of extending corneal graft survival
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
MXPA04008903A
(es)
|
2002-03-11 |
2004-11-26 |
Alcon Inc |
Sistema de suministro de farmaco implantable.
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US7919075B1
(en)
|
2002-03-20 |
2011-04-05 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
WO2003087368A2
(en)
*
|
2002-04-18 |
2003-10-23 |
Lynkeus Bio Tech Gmbh |
Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
ZA200408449B
(en)
|
2002-05-17 |
2007-09-26 |
Othera Pharmaceuticals Inc |
Amelioration of the development of cataracts and other opthalmic diseases
|
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
|
US7033602B1
(en)
|
2002-06-21 |
2006-04-25 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of coating implantable medical devices
|
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
US7056523B1
(en)
|
2002-06-21 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
|
|
US7217426B1
(en)
|
2002-06-21 |
2007-05-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings containing polycationic peptides for cardiovascular therapy
|
|
US6994867B1
(en)
|
2002-06-21 |
2006-02-07 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing L-arginine
|
|
US7011842B1
(en)
|
2002-06-21 |
2006-03-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
US7070798B1
(en)
|
2002-06-21 |
2006-07-04 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
|
|
US8506617B1
(en)
|
2002-06-21 |
2013-08-13 |
Advanced Cardiovascular Systems, Inc. |
Micronized peptide coated stent
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
US6930127B2
(en)
*
|
2002-08-15 |
2005-08-16 |
Eaton Veterinary Laboratories, Inc. |
Veterinary treatment of ophthalmic disease in animals using topical tacrolimus
|
|
US7087263B2
(en)
|
2002-10-09 |
2006-08-08 |
Advanced Cardiovascular Systems, Inc. |
Rare limiting barriers for implantable medical devices
|
|
WO2004036182A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US6896965B1
(en)
|
2002-11-12 |
2005-05-24 |
Advanced Cardiovascular Systems, Inc. |
Rate limiting barriers for implantable devices
|
|
US7022372B1
(en)
|
2002-11-12 |
2006-04-04 |
Advanced Cardiovascular Systems, Inc. |
Compositions for coating implantable medical devices
|
|
US20050013845A1
(en)
*
|
2002-11-12 |
2005-01-20 |
Warren Stephen L. |
Adhesive bioerodible ocular drug delivery system
|
|
US6982004B1
(en)
|
2002-11-26 |
2006-01-03 |
Advanced Cardiovascular Systems, Inc. |
Electrostatic loading of drugs on implantable medical devices
|
|
US7758880B2
(en)
|
2002-12-11 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible polyacrylate compositions for medical applications
|
|
US7776926B1
(en)
|
2002-12-11 |
2010-08-17 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible coating for implantable medical devices
|
|
US7074276B1
(en)
|
2002-12-12 |
2006-07-11 |
Advanced Cardiovascular Systems, Inc. |
Clamp mandrel fixture and a method of using the same to minimize coating defects
|
|
US7094256B1
(en)
|
2002-12-16 |
2006-08-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical device containing polycationic peptides
|
|
US8435550B2
(en)
|
2002-12-16 |
2013-05-07 |
Abbot Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
US20060002968A1
(en)
|
2004-06-30 |
2006-01-05 |
Gordon Stewart |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
|
|
US7758881B2
(en)
|
2004-06-30 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
EP1592435A4
(en)
*
|
2002-12-20 |
2008-01-23 |
Chakshu Res Inc |
EYE FORMULATION FOR THE PREVENTION AND TREATMENT OF EYE DRESS
|
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
|
US8185209B2
(en)
*
|
2003-01-03 |
2012-05-22 |
Board Of Trustees Operating Michigan State University |
Methods to extend vision to infrared wavelengths
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
ATE477337T1
(de)
|
2003-01-16 |
2010-08-15 |
Univ Pennsylvania |
Zusammensetzungen und verfahren zur sirna-hemmung von icam-1
|
|
US6926919B1
(en)
|
2003-02-26 |
2005-08-09 |
Advanced Cardiovascular Systems, Inc. |
Method for fabricating a coating for a medical device
|
|
US7063884B2
(en)
|
2003-02-26 |
2006-06-20 |
Advanced Cardiovascular Systems, Inc. |
Stent coating
|
|
US7563483B2
(en)
|
2003-02-26 |
2009-07-21 |
Advanced Cardiovascular Systems Inc. |
Methods for fabricating a coating for implantable medical devices
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7012106B2
(en)
*
|
2003-03-28 |
2006-03-14 |
Ethicon, Inc. |
Reinforced implantable medical devices
|
|
US7572298B2
(en)
*
|
2003-03-28 |
2009-08-11 |
Ethicon, Inc. |
Implantable medical devices and methods for making same
|
|
WO2004098565A2
(en)
|
2003-05-02 |
2004-11-18 |
Surmodics, Inc. |
Implantable controlled release bioactive agent delivery device
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
US20040225250A1
(en)
|
2003-05-05 |
2004-11-11 |
Michael Yablonski |
Internal shunt and method for treating glaucoma
|
|
US7279174B2
(en)
|
2003-05-08 |
2007-10-09 |
Advanced Cardiovascular Systems, Inc. |
Stent coatings comprising hydrophilic additives
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US20050118344A1
(en)
|
2003-12-01 |
2005-06-02 |
Pacetti Stephen D. |
Temperature controlled crimping
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US7875272B2
(en)
*
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
US8790637B2
(en)
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
US9579351B2
(en)
|
2003-06-27 |
2017-02-28 |
DePuy Synthes Products, Inc. |
Postpartum cells derived from placental tissue, and methods of making and using the same
|
|
US8491883B2
(en)
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7056591B1
(en)
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
|
US7785512B1
(en)
|
2003-07-31 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
|
|
US7431959B1
(en)
|
2003-07-31 |
2008-10-07 |
Advanced Cardiovascular Systems Inc. |
Method and system for irradiation of a drug eluting implantable medical device
|
|
US7645474B1
(en)
|
2003-07-31 |
2010-01-12 |
Advanced Cardiovascular Systems, Inc. |
Method and system of purifying polymers for use with implantable medical devices
|
|
CN102144961A
(zh)
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7955616B2
(en)
*
|
2003-09-23 |
2011-06-07 |
Orthocon, Inc. |
Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
|
|
US7989000B2
(en)
*
|
2003-09-23 |
2011-08-02 |
Orthocon, Inc. |
Absorbable putty-like implants and methods for their use for mechanical hemostasis of bone and for the treatment of osseous defects
|
|
CN102579162A
(zh)
*
|
2003-09-23 |
2012-07-18 |
奥索康公司 |
可吸收的植入体和它们用于止血和治疗骨缺损的方法
|
|
US7441513B1
(en)
|
2003-09-26 |
2008-10-28 |
Advanced Cardiovascular Systems, Inc. |
Plasma-generated coating apparatus for medical devices and a method of coating deposition
|
|
US8016865B2
(en)
|
2003-09-29 |
2011-09-13 |
Depuy Mitek, Inc. |
Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw
|
|
US7318932B2
(en)
|
2003-09-30 |
2008-01-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices comprising hydrolitically stable adducts of poly(ethylene-co-vinyl alcohol) and methods for fabricating the same
|
|
US7198675B2
(en)
|
2003-09-30 |
2007-04-03 |
Advanced Cardiovascular Systems |
Stent mandrel fixture and method for selectively coating surfaces of a stent
|
|
US7704544B2
(en)
|
2003-10-07 |
2010-04-27 |
Advanced Cardiovascular Systems, Inc. |
System and method for coating a tubular implantable medical device
|
|
US7329413B1
(en)
|
2003-11-06 |
2008-02-12 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US7291125B2
(en)
*
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
|
CN100558360C
(zh)
*
|
2003-11-20 |
2009-11-11 |
奥特拉控股公司 |
羟胺组合物在制备缓解黄斑变性和其他眼科疾病的药物中的用途
|
|
US8192752B2
(en)
|
2003-11-21 |
2012-06-05 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
|
|
US7560492B1
(en)
|
2003-11-25 |
2009-07-14 |
Advanced Cardiovascular Systems, Inc. |
Polysulfone block copolymers as drug-eluting coating material
|
|
US7807722B2
(en)
|
2003-11-26 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial coating compositions and methods of making and using thereof
|
|
US7431709B2
(en)
*
|
2003-12-05 |
2008-10-07 |
Innfocus, Llc |
Glaucoma implant device
|
|
AU2004297967C1
(en)
*
|
2003-12-05 |
2011-10-27 |
Innolene Llc |
Improved ocular lens
|
|
US7220816B2
(en)
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
|
US7435788B2
(en)
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US8309112B2
(en)
|
2003-12-24 |
2012-11-13 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
|
|
US7563324B1
(en)
|
2003-12-29 |
2009-07-21 |
Advanced Cardiovascular Systems Inc. |
System and method for coating an implantable medical device
|
|
US7976520B2
(en)
*
|
2004-01-12 |
2011-07-12 |
Nulens Ltd. |
Eye wall anchored fixtures
|
|
US20070053963A1
(en)
*
|
2004-01-13 |
2007-03-08 |
Hotchkiss Robert N |
Drug delivery to a joint
|
|
CN100548271C
(zh)
|
2004-01-20 |
2009-10-14 |
阿勒根公司 |
用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
|
|
US7794704B2
(en)
|
2004-01-23 |
2010-09-14 |
Advanced Cell Technology, Inc. |
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
|
|
WO2005070011A2
(en)
|
2004-01-23 |
2005-08-04 |
Advanced Cell Technology, Inc. |
Improved modalities for the treatment of degenerative diseases of the retina
|
|
US8685431B2
(en)
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
|
US8551512B2
(en)
|
2004-03-22 |
2013-10-08 |
Advanced Cardiovascular Systems, Inc. |
Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
|
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
|
CA2563150A1
(en)
|
2004-04-06 |
2005-10-20 |
Surmodics, Inc. |
Coating compositions for bioactive agents
|
|
US20050232972A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
WO2006033020A2
(en)
*
|
2004-04-26 |
2006-03-30 |
Rosetta Genomics Ltd. |
Methods and apparatus for the detection and validation of micrornas
|
|
US7553377B1
(en)
|
2004-04-27 |
2009-06-30 |
Advanced Cardiovascular Systems, Inc. |
Apparatus and method for electrostatic coating of an abluminal stent surface
|
|
US7820732B2
(en)
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US8591885B2
(en)
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
WO2005110374A1
(en)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US8512738B2
(en)
*
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
AU2005240078A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US8722097B2
(en)
*
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US8293890B2
(en)
|
2004-04-30 |
2012-10-23 |
Advanced Cardiovascular Systems, Inc. |
Hyaluronic acid based copolymers
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
CN1964711A
(zh)
*
|
2004-05-25 |
2007-05-16 |
奥特拉药物公司 |
眼睛选择性药物及前体药物
|
|
US9561309B2
(en)
|
2004-05-27 |
2017-02-07 |
Advanced Cardiovascular Systems, Inc. |
Antifouling heparin coatings
|
|
US7563780B1
(en)
|
2004-06-18 |
2009-07-21 |
Advanced Cardiovascular Systems, Inc. |
Heparin prodrugs and drug delivery stents formed therefrom
|
|
EP1765336A4
(en)
|
2004-06-25 |
2010-03-10 |
Univ Johns Hopkins |
ANGIOGENESIS INHIBITORS
|
|
US20050287184A1
(en)
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
|
CA2572592C
(en)
*
|
2004-07-02 |
2015-09-08 |
Eliot Lazar |
Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
|
|
US20060110428A1
(en)
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
|
CA2573668A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Ophthalmic compositions and methods for treating ophthalmic conditions
|
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
|
US8357391B2
(en)
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
|
US7494665B1
(en)
|
2004-07-30 |
2009-02-24 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing siloxane monomers
|
|
US7311980B1
(en)
|
2004-08-02 |
2007-12-25 |
Advanced Cardiovascular Systems, Inc. |
Polyactive/polylactic acid coatings for an implantable device
|
|
WO2006078320A2
(en)
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
US7648727B2
(en)
|
2004-08-26 |
2010-01-19 |
Advanced Cardiovascular Systems, Inc. |
Methods for manufacturing a coated stent-balloon assembly
|
|
US7244443B2
(en)
|
2004-08-31 |
2007-07-17 |
Advanced Cardiovascular Systems, Inc. |
Polymers of fluorinated monomers and hydrophilic monomers
|
|
US8603528B2
(en)
*
|
2004-09-16 |
2013-12-10 |
Abyrx, Inc. |
Compositions and method for the reduction of post-operative pain
|
|
US8110211B2
(en)
|
2004-09-22 |
2012-02-07 |
Advanced Cardiovascular Systems, Inc. |
Medicated coatings for implantable medical devices including polyacrylates
|
|
WO2006039333A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
CA2582096C
(en)
|
2004-10-01 |
2014-01-07 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US7166680B2
(en)
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
|
WO2006042252A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Potentia Pharmeceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
US8043609B2
(en)
|
2004-10-08 |
2011-10-25 |
Potentia Pharmaceuticals, Inc. |
Viral complement control proteins for eye disorders
|
|
US20060089590A1
(en)
*
|
2004-10-27 |
2006-04-27 |
John Higuchi |
Methods and devices for sustained in-vivo release of an active agent
|
|
US8603634B2
(en)
|
2004-10-27 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
End-capped poly(ester amide) copolymers
|
|
US7481835B1
(en)
|
2004-10-29 |
2009-01-27 |
Advanced Cardiovascular Systems, Inc. |
Encapsulated covered stent
|
|
US7390497B2
(en)
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
|
US7547447B2
(en)
*
|
2004-11-15 |
2009-06-16 |
Doheny Eye Institute |
Bioartificial lacrimal gland
|
|
WO2006053428A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Joanne Mclaurin |
Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
|
|
US20060110429A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Therakine Corporation |
Implant for intraocular drug delivery
|
|
US7214759B2
(en)
|
2004-11-24 |
2007-05-08 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same
|
|
US7588642B1
(en)
|
2004-11-29 |
2009-09-15 |
Advanced Cardiovascular Systems, Inc. |
Abluminal stent coating apparatus and method using a brush assembly
|
|
US8609123B2
(en)
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
|
US7892592B1
(en)
|
2004-11-30 |
2011-02-22 |
Advanced Cardiovascular Systems, Inc. |
Coating abluminal surfaces of stents and other implantable medical devices
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
US7632307B2
(en)
|
2004-12-16 |
2009-12-15 |
Advanced Cardiovascular Systems, Inc. |
Abluminal, multilayer coating constructs for drug-delivery stents
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US7604818B2
(en)
|
2004-12-22 |
2009-10-20 |
Advanced Cardiovascular Systems, Inc. |
Polymers of fluorinated monomers and hydrocarbon monomers
|
|
ES2621847T3
(es)
|
2004-12-23 |
2017-07-05 |
DePuy Synthes Products, Inc. |
Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
|
|
DK1835924T3
(da)
|
2004-12-23 |
2013-11-04 |
Ethicon Inc |
Behandling af parkinsons sygdom og beslægtede sygdomme under anvendelse af postpartum opnåede celler
|
|
US7419504B2
(en)
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
|
US8007775B2
(en)
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
|
US7202325B2
(en)
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
EP1858542A4
(en)
*
|
2005-02-24 |
2009-08-19 |
Joslin Diabetes Center Inc |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF VASPEREPERMABILITY
|
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
US20070077270A1
(en)
*
|
2005-03-28 |
2007-04-05 |
Clemson University |
Delivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear
|
|
US7795467B1
(en)
|
2005-04-26 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Bioabsorbable, biobeneficial polyurethanes for use in medical devices
|
|
US8778375B2
(en)
|
2005-04-29 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Amorphous poly(D,L-lactide) coating
|
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US7637941B1
(en)
|
2005-05-11 |
2009-12-29 |
Advanced Cardiovascular Systems, Inc. |
Endothelial cell binding coatings for rapid encapsulation of bioerodable stents
|
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
|
US7622070B2
(en)
|
2005-06-20 |
2009-11-24 |
Advanced Cardiovascular Systems, Inc. |
Method of manufacturing an implantable polymeric medical device
|
|
US7823533B2
(en)
|
2005-06-30 |
2010-11-02 |
Advanced Cardiovascular Systems, Inc. |
Stent fixture and method for reducing coating defects
|
|
US8021676B2
(en)
|
2005-07-08 |
2011-09-20 |
Advanced Cardiovascular Systems, Inc. |
Functionalized chemically inert polymers for coatings
|
|
US7749530B2
(en)
*
|
2005-07-13 |
2010-07-06 |
Allergan, Inc. |
Kinase inhibitors
|
|
EP1907006A2
(en)
*
|
2005-07-15 |
2008-04-09 |
Chakshu Research, Inc. |
Prevention and treatment of ophthalmic complications of diabetes
|
|
CA2615990A1
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
|
US7785647B2
(en)
|
2005-07-25 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Methods of providing antioxidants to a drug containing product
|
|
JP2009502928A
(ja)
*
|
2005-07-25 |
2009-01-29 |
オーソコン・インコーポレイテッド |
術後疼痛軽減用組成物および軽減方法
|
|
JP2009502954A
(ja)
|
2005-07-27 |
2009-01-29 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド |
タンパク質のミスフォールディングを修正する小分子及びその使用
|
|
US7735449B1
(en)
|
2005-07-28 |
2010-06-15 |
Advanced Cardiovascular Systems, Inc. |
Stent fixture having rounded support structures and method for use thereof
|
|
US7261529B2
(en)
*
|
2005-09-07 |
2007-08-28 |
Southwest Research Institute |
Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
|
|
US7758778B2
(en)
*
|
2005-09-07 |
2010-07-20 |
Southwest Research Institute |
Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents
|
|
US9693967B2
(en)
*
|
2005-09-07 |
2017-07-04 |
Southwest Research Institute |
Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
|
|
CA2602440A1
(en)
*
|
2005-09-16 |
2007-04-05 |
Allergan, Inc. |
Compositions and methods for the intraocular transport of therapeutic agents
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
WO2007119108A2
(en)
*
|
2005-10-13 |
2007-10-25 |
Waratah Pharmaceuticals Inc. |
Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
|
|
MX339797B
(es)
|
2005-10-18 |
2016-06-10 |
Allergan Inc |
Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
|
|
US20070225217A1
(en)
|
2005-11-09 |
2007-09-27 |
Combinatorx, Incorporated |
Methods, compositions, and kits for the treatment of medical conditions
|
|
JP5180834B2
(ja)
|
2005-11-29 |
2013-04-10 |
スミスクライン ビーチャム コーポレーション |
治療方法
|
|
US7976891B1
(en)
|
2005-12-16 |
2011-07-12 |
Advanced Cardiovascular Systems, Inc. |
Abluminal stent coating apparatus and method of using focused acoustic energy
|
|
JP5289970B2
(ja)
|
2005-12-16 |
2013-09-11 |
エシコン・インコーポレイテッド |
組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
|
|
US7591841B2
(en)
|
2005-12-16 |
2009-09-22 |
Advanced Cardiovascular Systems, Inc. |
Implantable devices for accelerated healing
|
|
US7638156B1
(en)
|
2005-12-19 |
2009-12-29 |
Advanced Cardiovascular Systems, Inc. |
Apparatus and method for selectively coating a medical article
|
|
US7867547B2
(en)
|
2005-12-19 |
2011-01-11 |
Advanced Cardiovascular Systems, Inc. |
Selectively coating luminal surfaces of stents
|
|
US8741638B2
(en)
|
2005-12-19 |
2014-06-03 |
DePuy Synthes Products, LLC |
In vitro expansion of postpartum-derived cells in roller bottles
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
WO2007077551A2
(en)
*
|
2005-12-30 |
2007-07-12 |
Mor Research Applications Ltd. |
Device and method for treating the anal sphincter
|
|
EP1979023B1
(en)
|
2006-01-17 |
2015-07-22 |
Transcend Medical, Inc. |
Glaucoma treatment device
|
|
US9084662B2
(en)
|
2006-01-17 |
2015-07-21 |
Transcend Medical, Inc. |
Drug delivery treatment device
|
|
EP2407171A3
(en)
|
2006-02-02 |
2012-04-11 |
Allergan, Inc. |
Compositions and methods for the treatment of ophthalmic disease
|
|
BRPI0707612B8
(pt)
|
2006-02-09 |
2021-05-25 |
Macusight Inc |
vaso lacrado e formulações líquidas contidas no mesmo
|
|
CA2642479C
(en)
*
|
2006-02-15 |
2014-08-19 |
Intec Pharma Ltd. |
A gastro-retentive system for the delivery of macromolecules
|
|
US20070197452A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Treatment of amyloid-related diseases
|
|
US20070196428A1
(en)
|
2006-02-17 |
2007-08-23 |
Thierry Glauser |
Nitric oxide generating medical devices
|
|
CA2642647A1
(en)
*
|
2006-02-17 |
2007-11-15 |
Joanne Mclaurin |
Compositions and methods for treatment of disorders of protein aggregation
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US7601383B2
(en)
|
2006-02-28 |
2009-10-13 |
Advanced Cardiovascular Systems, Inc. |
Coating construct containing poly (vinyl alcohol)
|
|
US7713637B2
(en)
|
2006-03-03 |
2010-05-11 |
Advanced Cardiovascular Systems, Inc. |
Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
|
|
EP1996175A4
(en)
*
|
2006-03-09 |
2009-06-10 |
Waratah Pharmaceuticals Inc |
CYCLOHEXAN POLYALKOHOL FORMULATION FOR THE TREATMENT OF PROTEIN AGGREGATION DISORDERS
|
|
WO2007112052A2
(en)
|
2006-03-23 |
2007-10-04 |
Macusight, Inc. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
CN103393483B
(zh)
|
2006-03-31 |
2016-08-24 |
玛提治疗有限公司 |
用于鼻泪系统的药物释放方法、结构及组合物
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US8069814B2
(en)
|
2006-05-04 |
2011-12-06 |
Advanced Cardiovascular Systems, Inc. |
Stent support devices
|
|
US8304012B2
(en)
|
2006-05-04 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Method for drying a stent
|
|
US7985441B1
(en)
|
2006-05-04 |
2011-07-26 |
Yiwen Tang |
Purification of polymers for coating applications
|
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
CA2652449A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Waratah Pharmaceuticals Inc. |
Screening methods for amyloid beta modulators
|
|
US7775178B2
(en)
|
2006-05-26 |
2010-08-17 |
Advanced Cardiovascular Systems, Inc. |
Stent coating apparatus and method
|
|
US8568764B2
(en)
|
2006-05-31 |
2013-10-29 |
Advanced Cardiovascular Systems, Inc. |
Methods of forming coating layers for medical devices utilizing flash vaporization
|
|
US9561351B2
(en)
|
2006-05-31 |
2017-02-07 |
Advanced Cardiovascular Systems, Inc. |
Drug delivery spiral coil construct
|
|
US8703167B2
(en)
|
2006-06-05 |
2014-04-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
|
|
US8778376B2
(en)
|
2006-06-09 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
|
|
DK2029746T3
(da)
|
2006-06-12 |
2012-10-08 |
Exegenics Inc D B A Opko Health Inc |
Sammensætninger og fremgangsmåder til siRNA-hæmning af angiogenese
|
|
US8603530B2
(en)
|
2006-06-14 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
Nanoshell therapy
|
|
US8114150B2
(en)
|
2006-06-14 |
2012-02-14 |
Advanced Cardiovascular Systems, Inc. |
RGD peptide attached to bioabsorbable stents
|
|
US8048448B2
(en)
|
2006-06-15 |
2011-11-01 |
Abbott Cardiovascular Systems Inc. |
Nanoshells for drug delivery
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
EP2826788B1
(en)
|
2006-06-21 |
2017-12-13 |
MUSC Foundation for Research Development |
Targeting complement factor h for treatment of diseases by the use of cr2-fh molecules
|
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US9028859B2
(en)
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
|
US8685430B1
(en)
|
2006-07-14 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Tailored aliphatic polyesters for stent coatings
|
|
US20080097335A1
(en)
|
2006-08-04 |
2008-04-24 |
Allergan, Inc. |
Ocular implant delivery assemblies
|
|
US8703169B1
(en)
|
2006-08-15 |
2014-04-22 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a coating comprising carrageenan and a biostable polymer
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
WO2008034244A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Waratah Pharmaceuticals Inc. |
The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases
|
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
US8039010B2
(en)
*
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
CA2668954C
(en)
|
2006-11-10 |
2020-09-08 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
|
US8143410B2
(en)
|
2006-11-16 |
2012-03-27 |
Allergan, Inc. |
Kinase inhibitors
|
|
US20100292157A1
(en)
*
|
2006-11-24 |
2010-11-18 |
Antonio Cruz |
Combination Treatments for Alzheimer's Disease and Similar Diseases
|
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
CA2670990A1
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
|
US8597673B2
(en)
|
2006-12-13 |
2013-12-03 |
Advanced Cardiovascular Systems, Inc. |
Coating of fast absorption or dissolution
|
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
EP2148691B1
(en)
|
2007-02-05 |
2015-05-20 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogues for use in the treatment of inflammatory conditions of the respiratory system
|
|
CN105998028A
(zh)
|
2007-02-22 |
2016-10-12 |
科尔比制药公司 |
羟胺化合物及其用法
|
|
US20100331267A1
(en)
*
|
2007-04-12 |
2010-12-30 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives in the treatment of alpha-synucleinopathies
|
|
WO2008124931A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
|
|
CA2683548A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
|
|
EP2656839A1
(en)
*
|
2007-04-12 |
2013-10-30 |
Waratah Pharmaceuticals, Inc. |
Use of Cyclohexanehexol Derivatives in the Treatment of Ocular Diseases
|
|
US8147769B1
(en)
|
2007-05-16 |
2012-04-03 |
Abbott Cardiovascular Systems Inc. |
Stent and delivery system with reduced chemical degradation
|
|
US9056155B1
(en)
|
2007-05-29 |
2015-06-16 |
Abbott Cardiovascular Systems Inc. |
Coatings having an elastic primer layer
|
|
US8048441B2
(en)
|
2007-06-25 |
2011-11-01 |
Abbott Cardiovascular Systems, Inc. |
Nanobead releasing medical devices
|
|
US8109904B1
(en)
|
2007-06-25 |
2012-02-07 |
Abbott Cardiovascular Systems Inc. |
Drug delivery medical devices
|
|
JP5582535B2
(ja)
*
|
2007-06-29 |
2014-09-03 |
クラレンス ピーティーワイ エルティーディー |
点眼投与による神経疾患または精神神経疾患の治療または予防
|
|
JP5328788B2
(ja)
|
2007-07-17 |
2013-10-30 |
トランセンド・メディカル・インコーポレイテッド |
ヒドロゲルの拡張能力を備えた眼内植込み体
|
|
DK2865361T3
(da)
|
2007-09-07 |
2019-07-08 |
Mati Therapeutics Inc |
Tåreimplantater og tilhørende fremgangsmåder
|
|
WO2009035571A2
(en)
*
|
2007-09-07 |
2009-03-19 |
Qlt Plug Delivery, Inc |
Lacrimal implant detection
|
|
JP5555162B2
(ja)
|
2007-09-07 |
2014-07-23 |
キュー エル ティー インク． |
治療薬剤の持続放出のための薬物コア
|
|
EP2203186B1
(en)
|
2007-10-05 |
2014-09-24 |
DePuy Synthes Products, LLC |
Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
|
|
AU2008312007A1
(en)
|
2007-10-12 |
2009-04-23 |
Advanced Cell Technology, Inc. |
Improved methods of producing RPE cells and compositions of RPE cells
|
|
WO2009076512A1
(en)
|
2007-12-11 |
2009-06-18 |
Epix Delaware, Inc. |
Carboxamidξ compounds and their use as chemokine receptor agonists
|
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
|
US8236538B2
(en)
|
2007-12-20 |
2012-08-07 |
Advanced Technologies And Regenerative Medicine, Llc |
Methods for sterilizing materials containing biologically active agents
|
|
SG188155A1
(en)
|
2008-02-18 |
2013-03-28 |
Quadra Logic Tech Inc |
Lacrimal implants and related methods
|
|
JP5552482B2
(ja)
|
2008-04-30 |
2014-07-16 |
キュー エル ティー インク． |
複合涙管挿入物および関連する方法
|
|
CA2722971C
(en)
|
2008-05-09 |
2019-05-07 |
Qlt Plug Delivery, Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
CA2723588A1
(en)
|
2008-05-12 |
2009-11-19 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated uses
|
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
EP3298995A1
(en)
|
2008-06-25 |
2018-03-28 |
Novartis AG |
Ocular implant with shape change capabilities
|
|
EP2340309A2
(en)
|
2008-09-22 |
2011-07-06 |
Rxi Pharmaceuticals Corporation |
Neutral nanotransporters
|
|
CN101390825B
(zh)
*
|
2008-10-01 |
2010-12-29 |
山东省眼科研究所 |
一种伏立康唑眼内释药系统
|
|
WO2010040232A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Waratah Pharmaceuticals Inc. |
Use of scyllo-inositols for the treatment of macular degeneration-related disorders
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
NZ593743A
(en)
|
2008-12-04 |
2012-07-27 |
Opko Ophthalmics Llc |
Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
|
|
BRPI0923068B1
(pt)
|
2008-12-19 |
2021-05-25 |
Advanced Technologies And Regenerative Medicine, Llc |
Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
|
|
US10179900B2
(en)
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
WO2010088258A2
(en)
|
2009-01-28 |
2010-08-05 |
Transcend Medical, Inc. |
Ocular implant with stiffness qualities, methods of implantation and system
|
|
US8399006B2
(en)
|
2009-01-29 |
2013-03-19 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
US9745574B2
(en)
|
2009-02-04 |
2017-08-29 |
Rxi Pharmaceuticals Corporation |
RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
|
CA2750242C
(en)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
EP3415124A3
(en)
|
2009-02-23 |
2019-02-27 |
Mati Therapeutics Inc. |
Lacrimal implants
|
|
WO2010101758A1
(en)
*
|
2009-03-03 |
2010-09-10 |
Alcon Research, Ltd. |
Peri-corneal drug delivery device
|
|
WO2010111663A1
(en)
|
2009-03-26 |
2010-09-30 |
Ethicon, Inc. |
Human umbilical cord tissue cells as therapy for alzheimer' s disease
|
|
EP3412260B1
(en)
|
2009-05-18 |
2020-08-26 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
IN2012DN00352A
(no)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8715706B2
(en)
*
|
2009-06-18 |
2014-05-06 |
RDD Pharma, Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
US20110129516A1
(en)
*
|
2009-10-30 |
2011-06-02 |
Aton Pharma, Inc. |
Ocular drug delivery devices
|
|
ES2695931T3
(es)
|
2009-11-09 |
2019-01-11 |
Allergan Inc |
Composiciones y métodos para estimular el crecimiento del pelo
|
|
IL281453B
(en)
|
2009-11-17 |
2022-07-01 |
Astellas Inst For Regenerative Medicine |
Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
|
|
CN102812126A
(zh)
*
|
2009-12-04 |
2012-12-05 |
奥普科制药有限责任公司 |
用于抑制vegf的组合物和方法
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
CA2794187C
(en)
|
2010-03-24 |
2020-07-14 |
Rxi Pharmaceuticals Corporation |
Rna interference in ocular indications
|
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
|
SG186397A1
(en)
|
2010-06-22 |
2013-01-30 |
Univ Colorado Regents |
Antibodies to the c3d fragment of complement component 3
|
|
AU2011270754B2
(en)
|
2010-06-25 |
2015-04-23 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Methods of treatment using sterculic acid
|
|
CA2806127C
(en)
|
2010-07-23 |
2021-12-21 |
Advanced Cell Technology, Inc. |
Methods for detection of rare subpopulations of cells and highly purified compositions of cells
|
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
AU2011285545B2
(en)
|
2010-08-05 |
2014-03-13 |
Forsight Vision4, Inc. |
Injector apparatus and method for drug delivery
|
|
WO2012019176A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4 Inc. |
Implantable therapeutic device
|
|
CA2818612C
(en)
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
WO2012131583A2
(en)
*
|
2011-03-27 |
2012-10-04 |
Microsert Ltd. |
Miniature implanted drug delivery devices and inserter systems for introducing such devices
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
CA2838974A1
(en)
|
2011-06-14 |
2012-12-20 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
|
EP2750660B1
(en)
|
2011-08-29 |
2016-10-12 |
Mati Therapeutics Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
EP4193907A1
(en)
|
2011-09-13 |
2023-06-14 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
US9883968B2
(en)
|
2011-09-16 |
2018-02-06 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
CN113786417A
(zh)
|
2011-11-14 |
2021-12-14 |
安斯泰来再生医药协会 |
人rpe细胞的药物制剂及其用途
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013086015A1
(en)
|
2011-12-05 |
2013-06-13 |
Incept, Llc |
Medical organogel processes and compositions
|
|
US9611513B2
(en)
|
2011-12-23 |
2017-04-04 |
DePuy Synthes Products, Inc. |
Detection of human umbilical cord tissue derived cells
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US10085633B2
(en)
|
2012-04-19 |
2018-10-02 |
Novartis Ag |
Direct visualization system for glaucoma treatment
|
|
BR102012009316A2
(pt)
*
|
2012-04-20 |
2013-11-26 |
Univ Minas Gerais |
Dispositivo de liberação prolongada de talidomida e uso em doenças oculares causadoras de neovascularização
|
|
US9241832B2
(en)
|
2012-04-24 |
2016-01-26 |
Transcend Medical, Inc. |
Delivery system for ocular implant
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
CA2874824C
(en)
|
2012-06-01 |
2021-10-26 |
Surmodics, Inc. |
Apparatus and methods for coating balloon catheters
|
|
EP3228286A1
(en)
|
2012-09-17 |
2017-10-11 |
Novartis AG |
Expanding ocular impant devices
|
|
WO2014071044A1
(en)
|
2012-11-01 |
2014-05-08 |
Allergan, Inc. |
Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
|
|
US9763829B2
(en)
|
2012-11-14 |
2017-09-19 |
Novartis Ag |
Flow promoting ocular implant
|
|
ES2780674T3
(es)
|
2012-11-15 |
2020-08-26 |
Apellis Pharmaceuticals Inc |
Análogos de compstatina de acción prolongada y composiciones y métodos relacionados
|
|
CN109602691A
(zh)
|
2013-02-15 |
2019-04-12 |
阿勒根公司 |
持续药物递送植入物
|
|
US10981961B2
(en)
|
2013-03-11 |
2021-04-20 |
University Of Florida Research Foundation, Incorporated |
Delivery of card protein as therapy for occular inflammation
|
|
SI2968461T1
(sl)
|
2013-03-13 |
2023-01-31 |
Genzyme Corporation |
Fuzijski proteini, ki vsebujejo vezavna dela PDGF in VEGF in postopek njihove uporabe
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US10308687B2
(en)
|
2013-03-15 |
2019-06-04 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
EP4302736A3
(en)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
US9987163B2
(en)
|
2013-04-16 |
2018-06-05 |
Novartis Ag |
Device for dispensing intraocular substances
|
|
WO2014179568A2
(en)
*
|
2013-05-02 |
2014-11-06 |
Odin Biotech |
Two-layer ocular implant
|
|
US10274503B2
(en)
|
2013-05-08 |
2019-04-30 |
Vegenics Pty Limited |
Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis
|
|
US9333208B2
(en)
|
2013-07-16 |
2016-05-10 |
Movses H. Karakossian |
HCN inhibitors affecting ganglion cell function and visual function
|
|
WO2015009533A1
(en)
|
2013-07-16 |
2015-01-22 |
Allergan, Inc. |
Gabaa receptor antagonists affecting ganglion cell function and visual function
|
|
EP3137119B1
(en)
|
2014-04-28 |
2020-07-01 |
Phio Pharmaceuticals Corp. |
Methods for treating cancer using a nucleic acid targeting mdm2
|
|
US20170051290A1
(en)
|
2014-05-01 |
2017-02-23 |
Rxi Pharmaceuticals Corporation |
Methods for treatment of disorders in the front of the eye utilizing nucleic acid molecules
|
|
JP6655610B2
(ja)
|
2014-05-29 |
2020-02-26 |
グローコス コーポレーション |
制御された薬物送達機能を備えるインプラント及びそれを使用する方法
|
|
US10562946B2
(en)
|
2014-06-20 |
2020-02-18 |
Genentech, Inc. |
Chagasin-based scaffold compositions, methods, and uses
|
|
ES2803102T3
(es)
|
2014-07-15 |
2021-01-22 |
Forsight Vision4 Inc |
Dispositivo de administración de implante ocular
|
|
CA2957548A1
(en)
|
2014-08-08 |
2016-02-11 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
US10912933B2
(en)
|
2014-08-19 |
2021-02-09 |
The Regents Of The University Of California |
Implants for localized drug delivery and methods of use thereof
|
|
US20180250224A1
(en)
*
|
2014-09-19 |
2018-09-06 |
Oxular Limited |
Ophthalmic Drug Compositions
|
|
CN114587774B
(zh)
|
2014-11-10 |
2024-07-19 |
弗赛特影像4股份有限公司 |
治疗眼睛的系统
|
|
CN105769430B
(zh)
*
|
2014-12-26 |
2018-09-28 |
易浦润（上海）生物技术有限公司 |
一种载药的泪小管栓子
|
|
US20180001581A1
(en)
|
2015-01-14 |
2018-01-04 |
Jayant K. Patel |
Compositions, systems and methods for patient specific ophthalmic device
|
|
US9820954B2
(en)
|
2015-08-19 |
2017-11-21 |
Jenivision Inc. |
Quantitative peri-orbital application of ophthalmology drugs
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
IL258525B2
(en)
|
2015-10-07 |
2023-03-01 |
Apellis Pharmaceuticals Inc |
Dosing regimens
|
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
|
PT109154B
(pt)
*
|
2016-02-12 |
2019-11-05 |
Univ De Coimbra |
Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
|
|
US10883108B2
(en)
|
2016-03-31 |
2021-01-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
AU2017246889B2
(en)
|
2016-04-05 |
2021-12-16 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Glaukos Corporation |
Bioresorbable ocular drug delivery device
|
|
US12226524B2
(en)
|
2016-05-02 |
2025-02-18 |
The Regents Of The University Of Michigan |
Coated implants for long-term controlled release of antibody therapeutics
|
|
JP2019524688A
(ja)
|
2016-07-05 |
2019-09-05 |
ヤンセン バイオテツク，インコーポレーテツド |
前駆細胞を用いた網膜血管疾患の治療
|
|
EP3541408B1
(en)
|
2016-11-15 |
2024-11-13 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for the treatment of aberrant angiogenesis
|
|
JP2020516607A
(ja)
|
2017-04-07 |
2020-06-11 |
アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
投与レジメンならびに関連組成物および方法
|
|
WO2019070917A1
(en)
|
2017-10-03 |
2019-04-11 |
The Schepens Eye Research Institute, Inc. |
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
|
|
EP3710008A4
(en)
|
2017-11-14 |
2021-08-25 |
The Schepens Eye Research Institute, Inc. |
INHIBITION OF RUNX1 FOR THE TREATMENT OF PROLIFERATIVE VITREORETINOPATHY AND CONDITIONS ASSOCIATED WITH EPITHELIAL TO MESENCHYMATIC TRANSITION
|
|
AU2018372806B2
(en)
|
2017-11-21 |
2024-05-30 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
|
AU2019263302C1
(en)
|
2018-05-01 |
2024-10-31 |
Chibi, Inc. |
Liquid depot for non-invasive sustained delivery of agents to the eye
|
|
WO2019213326A1
(en)
*
|
2018-05-01 |
2019-11-07 |
Idrop, Inc. |
Eye drop formulation and method for sustained delivery of medicament to the retina
|
|
EP3803866A4
(en)
|
2018-05-24 |
2022-03-16 |
Nureva Inc. |
METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
|
|
MX2020012458A
(es)
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
|
CN111989068B
(zh)
|
2018-05-24 |
2024-10-25 |
塞拉尼斯伊娃高性能聚合物公司 |
用于持续释放大分子药物化合物的可植入器件
|
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
CA3149866A1
(en)
|
2019-10-24 |
2021-04-29 |
Denis E. Labombard |
Ocular device and drug delivery system, with case
|
|
US11173291B2
(en)
|
2020-03-20 |
2021-11-16 |
The Regents Of The University Of California |
Implantable drug delivery devices for localized drug delivery
|
|
US11344526B2
(en)
|
2020-03-20 |
2022-05-31 |
The Regents Of The University Of California |
Implantable drug delivery devices for localized drug delivery
|
|
US11338119B2
(en)
|
2020-03-20 |
2022-05-24 |
The Regents Of The University Of California |
Implantable drug delivery devices for localized drug delivery
|
|
WO2023105417A1
(en)
|
2021-12-06 |
2023-06-15 |
Breye Therapeutics Aps |
Danegaptide formulation for applicatoin in the eye
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
CN118946333A
(zh)
*
|
2022-01-24 |
2024-11-12 |
塞拉尼斯伊娃高性能聚合物公司 |
用于预防和/或治疗眼部病症的方法
|
|
WO2025015317A2
(en)
|
2023-07-13 |
2025-01-16 |
Kriya Therapeutics, Inc. |
Complement pathway inhibitor fusions and methods of using the same
|